🇺🇸 FDA
Pipeline program

250 mg capsule

LX1033.1-103-NRM

Phase 1 small_molecule completed

Quick answer

250 mg capsule for Irritable Bowel Syndrome is a Phase 1 program (small_molecule) at LEXICON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
LEXICON PHARMACEUTICALS, INC.
Indication
Irritable Bowel Syndrome
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials